Skip to main content
Premium Trial:

Request an Annual Quote

Decode Genetics Increases Amount on Promissory Note

NEW YORK (GenomeWeb News) – Decode Genetics disclosed in a filing yesterday with the US Securities and Exchange Commission that it has increased the principal amount of a recent promissory note to $2.9 million.

The increase was the second time that Decode has increased the amount of the note.

In early September, the firm initially executed the promissory note with Saga Investments with a principal amount of $700,000, which had an interest rate of 8 percent per annum and was payable in full on Oct. 11, 2009. Then last week, it disclosed that the principal amount had been increased to $1.87 million. The other terms of the initial agreement with Saga remain in place, Decode said in the filing yesterday.

The firm had also said last week that it will close its Woodridge, Ill., facility and eliminate around 60 positions.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.